Discover
EDSA
Edesa Biotech, Inc.
4.14
2 x 2.67
2 x 5.08
bid
ask
+
0.00
0.00%
2 @ 07:54 PM
4.10 -0.04 (0.97%)
| Ytd | 191.55% | |
| 1y | 80.00% |
4.01
day range
4.14
0.80
52 week range
18.28
| Open | 4.03 | Prev Close | 4.14 | Low | 4.01 | High | 4.14 | Mkt Cap | 39.91M |
| Vol | 41.40K | Avg Vol | 74.20K | EPS | -1.72 | P/E | N/A | Forward P/E | -0.89 |
| Beta | 0.84 | Short Ratio | 0.76 | Inst. Own | 12.20% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 5.26 | 200-d Avg | 5.38 | 1yr Est | 20.50 |
| Income Statement | |||
| Operating Expenses | 5.52M | ||
| Research and Development Expense | 3.96M | ||
| Selling, General and Administrative Expense | 1.56M | ||
| Operating Income | -5.52M | ||
| Net Income | -5.41M | ||
| Net Income Common Stock | -5.41M | ||
| Net Income Common Stock (USD) | -5.41M | ||
| Consolidated Income | -5.41M | ||
| Earnings per Basic Share | -0.60 | ||
| Earnings per Basic Share (USD) | -0.60 | ||
| Earnings per Diluted Share | -0.60 | ||
| Earning Before Interest & Taxes (EBIT) | -5.41M | ||
| Earning Before Interest & Taxes (USD) | -5.41M | ||
| Weighted Average Shares | 9.01M | ||
| Weighted Average Shares Diluted | 9.01M | ||
| Balance Sheet | |||
| Cash and Equivalents | 10.33M | ||
| Cash and Equivalents (USD) | 10.33M | ||
| Investments | 39.12K | ||
| Investments Non-Current | 39.12K | ||
| Trade and Non-Trade Receivables | 228.05K | ||
| Current Assets | 10.78M | ||
| Total Assets | 12.72M | ||
| Current Liabilities | 3.91M | ||
| Total Liabilities | 3.91M | ||
| Accumulated Retained Earnings (Deficit) | -77.90M | ||
| Accumulated Other Comprehensive Income | -158.54K | ||
| Shareholders Equity | 8.81M | ||
| Shareholders Equity (USD) | 8.81M | ||
| Assets Non-Current | 1.94M | ||
| Goodwill and Intangible Assets | 1.90M | ||
| Trade and Non-Trade Payables | 3.91M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 25.64K | ||
| Net Cash Flow from Financing | 3.45M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 328.84K | ||
| Issuance (Purchase) of Equity Shares | 3.45M | ||
| Net Cash Flow from Operations | -3.08M | ||
| Effect of Exchange Rate Changes on Cash | -35.43K | ||
| Share Based Compensation | 547.46K | ||